The NGF System and its interplay with endocannabinoid signalling, from peripheral sensory terminals to the brain: new targets for the development of next generation drugs for neuropathic pain

The Ethical Committee is composed of one member for each partner either from their scientific team or from their institute administration, with a strong knowledge of ethical issue.


Simona Capsoni Scuola Normale Superiore
Michela Giustizieri European Brain Research Institute
Christian Vægter Aarhus Universitet
Tibor Harkany Medizinische Universitet Wien
Simon Westbrook Levicept LTD
Marzia Malcangio King’s College London
Juan Carlos Arevalo Universidad Salamanca
Anna Moles Genomnia SRL
Giovanni Marsicano Institut National de la Santé et de la Recherche Médicale


  • identify the ethical issues at stake with regard to the development, characterisation and use of animal models, as well as the potential safety and liability issues of the therapies under development, and then advise the consortium on the nature research activities, to anticipate the ethic issues and to take actions in order to make the researchers aware about such issues
  • keeping the participants well-informed about the new ethical regulations relevant to the PAINCAGE project.
  • ensuring that the existing ethical rules are met.
  • increasing the researchers’ awareness of ethical issues.

Members will participate in European meetings relevant to the ethical issues arising from the work.